CAROLINE BUCKWAY, MD
Medical Practice in Palo Alto, CA
License number
California A60707
Category
Medical Practice
Type
Pediatric Endocrinology
Address
Address
300 Pasteur Dr. G313, Palo Alto, CA 94305
Phone
(650) 723-5791
(650) 725-8375 (Fax)
(650) 725-8375 (Fax)
Organization information
See more information about CAROLINE BUCKWAY at bizstanding.comCaroline Buckway MD
730 Welch Rd, Palo Alto, CA 94304
Industry:
Pediatric Endocrinologist, Pediatrician, Internist
Phone:
(650) 498-4224 (Phone)
Caroline Katharine Buckway
Professional information
Caroline Buckway, Stanford CA
Specialties:
Pediatric Endocrinologist
Address:
300 Pasteur Dr, Stanford, CA 94305
Education:
University of Utah, School of Medicine - Doctor of Medicine
Board certifications:
American Board of Pediatrics Certification in Pediatrics, American Board of Pediatrics Sub-certificate in Pediatric Endocrinology (Pediatrics)
Caroline Katharine Buckway, Palo Alto CA
Specialties:
Pediatrics, Pediatric Endocrinology, Endocrinology, Diabetes & Metabolism
Work:
Medicine Specialties
730 Welch Rd, Palo Alto, CA 94304 Stanford Hospital
300 Pasteur Dr, Palo Alto, CA 94304 Stanford University
300 Pasteur Dr, Stanford, CA 94305
730 Welch Rd, Palo Alto, CA 94304 Stanford Hospital
300 Pasteur Dr, Palo Alto, CA 94304 Stanford University
300 Pasteur Dr, Stanford, CA 94305
Education:
University of Utah (1995)
Dr. Caroline Buckway, Palo Alto CA - MD (Doctor of Medicine)
Specialties:
Pediatric Endocrinology
Address:
Lucille Packard Child Hosp Endo
730 Welch Rd STE 2, Palo Alto 94304
(650) 723-5791 (Phone)
730 Welch Rd STE 2, Palo Alto 94304
(650) 723-5791 (Phone)
Certifications:
Pediatric Endocrinology, 2009, Pediatrics, 2006
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Utah
Graduated: 1995
Stanford University
Oreg Hlth Scis Ctr
University of Utah
Graduated: 1995
Stanford University
Oreg Hlth Scis Ctr
Mutant Igfbp-3 Molecules That Do Not Bind To Igfs, But Retain Their Ability To Functionally Bind Igfbp-3 Receptor
US Patent:
7514532, Apr 7, 2009
Filed:
Mar 7, 2007
Appl. No.:
11/715600
Inventors:
Youngman Oh - Glen Allen VA, US
Ron G. Rosenfeld - Los Altos CA, US
Caroline K. Buckway - Stanford CA, US
Ron G. Rosenfeld - Los Altos CA, US
Caroline K. Buckway - Stanford CA, US
Assignee:
Oregon Health & Science University - Portland OR
International Classification:
A61K 38/00
US Classification:
530324, 530350
Abstract:
There is disclosed novel mutant IGFBP-3 polypeptides and fragments thereof that have either no binding, or diminished binding to IGFs, yet retain their ability to bind to the human IGFBP-3 receptor (“P4. 33”). The present invention provides novel mutant IGFBP-3 nucleic acid sequences, and expression systems. Additional embodiments provide for screening assays for identifying IGFBP-3 receptor antagonists or agonists, methods for modulating IGF-independent IGFBP-3 responses of cells expressing IGFBP-3 receptors, A methods for inducing or potentiating apoptosis of cells expressing IGFBP-3 receptors, methods for treating solid tumors having cells expressing IGFBP-3 receptors, and compositions comprising polypeptides having either no binding, or diminished binding to IGFs, yet retain their ability to bind to the IGFBP-3 receptor.